Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases

Area of Science:

• Endocrinology
• Cell Biology
• Cancer Research

Background:

• Thyroid hormones (TH) are crucial for cellular processes, including cell migration.
• Cell migration involves actin remodeling and focal adhesion dynamics.
• Focal adhesion kinase (FAK) regulates cell migration and invasion by controlling focal adhesion turnover.

Purpose of the Study:

• To investigate the role of thyroid hormone triiodothyronine (T3) in regulating breast cancer cell migration.
• To elucidate the mechanism by which T3 influences cell movement, focusing on FAK recruitment and signaling pathways.

Main Methods:

• Utilized T-47D breast cancer cells.
• Established cellular models with normal, absent, and excess T3 concentrations.
• Analyzed the phosphorylation and translocation of FAK.
• Investigated signaling pathways involving integrin αV/β3, Src, and phosphatidylinositol 3-OH kinase (PI3K).

Main Results:

• T3 was found to regulate actin remodeling and cell movement in T-47D cells via FAK recruitment.
• T3 controls FAK phosphorylation and translocation to focal adhesion sites.
• Signaling pathways including integrin αV/β3, Src, PI3K, and FAK are rapidly activated by T3.
• Src, FAK, and PI3K expression remained normal in excess T3 but were reduced in the absence of T3.

Conclusions:

• T3 acts as a novel modulator of cell migration in breast cancer.
• The findings highlight a new mechanism involving T3, FAK, and associated signaling pathways in breast cancer cell motility.
• This research provides a basis for developing novel therapeutic strategies targeting T3-mediated cell migration in breast cancer treatment.